Hemodialysis And Peritoneal Dialysis Market By Type (Hemodialysis, Peritoneal Dialysis), By Product (Services, Devices, Consumables) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The hemodialysis and peritoneal dialysis market is valued at US$ 63,796.2 Mn in 2017 and is set to grow with a compounded annual growth rate (CAGR) of 6.2% during the forecast period from 2018 to 2026. According to the latest research citing of National Kidney Foundation 10% of the global population is suffering with chronic kidney disease eventually resulting into mortality of millions of people annually due to lack of access to effective treatment.

Weight Management Market By Weight Loss Products Type (Dietary Products, Drugs & Supplements, and Cosmetics), By Fitness Equipment Type (Cardio Training Equipment, Strength Training Equipment, Body Composition Analyzers, and Fitness Monitoring Equipment), By Surgical Services Type (Invasive Surgeries, And Non-Invasive Surgeries) - Growth, Future Prospects, And Competitive Analysis, 2016 - 2024

$ 4325

The report titled “Weight Management Market- Growth, Future Prospects, and Competitive Analysis, 2016 – 2024” offers strategic insights into the overall weight management market along with the market size and estimates for the duration 2014 to 2024. The said research study covers in-depth analysis of multiple market segments based on type of weight loss products, fitness equipment, surgical services and different geographies. Weight management market is a dynamic market; the companies are expected to keep in the mind that people nowadays are watching weight rather than dieting. Hence, the products should be positioned in the market as fitness contributors.

Recombinant Plasma Protein Therapeutics Market By Drug Class (Recombinant Factor VIII and Recombinant Factor IX), By Cell Line (Chinese Hamster Ovary, Baby Hamster Kidney and Human Embryonic Kidney and Other), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease and Other) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The recombinant plasma protein therapeutics market is set to grow from US$ 7,788.9 Mn in 2017 to US$ 15,910.5 Mn in 2026 expanding at an annual growth rate of 8.3% during the forecast period from 2018 to 2026. According to World Federation of Hemophilia (WFH), approximately 1 in 1,000 people worldwide suffer with some form of bleeding disorder, 75% of them gain inadequate treatment and remain undiagnosed.

Gonorrhea Diagnostics Market - Growth, Future Prospects & Competitive Analysis, 2018-2026

$ 4325

Gonorrhea is caused due to the infection of bacterium Neisseria gonorrhea which usually affects the moist and warm areas of the body such as vagina, anus, urethra, throat and eyes. It is classified as the second most occurring sexually transmitted disease (STD) as it has the risk to spread through unprotected sex or having multiple sex partners. Due to high morbidity rate and eminent threat of gonorrhea being resistant to cephalosporin, makes it necessary to understand the disease epidemiology of gonorrhea.

Proton Therapy Market By Type (Compact Systems, Multiple Rooms Systems), By Indication (Pelvic Cancers, Thorax Area Cancers, Gastrointestinal Cancers, Pediatric Tumors, Lymphomas, Head And Neck Cancers, Brain Cancer, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

Interest in investing and developing in proton therapy has exponentially increased over the past few decades, including the clinical advantage of Bragg peak dose as against the conventional high-energy X-ray distribution of photons.

Pressure Ulcer Treatment Products Market By Product Type (Pressure Relief Devices, Wound Dressings, Wound Care Devices, Others), By Wound Type (Stage 1 & 2, Stage 3 & 4, Unstageable And Deep Tissue Injury), By Usage Area (Hospitals, Nursing Homes, Home Care) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

In the U.S. the prevalence of pressure ulcers in intensive care units ranges from 16.6% to 20.7%. It is also reported that annually US$ 11 billion is spent on the treatment of pressure ulcers, with US$ 500 to US$ 70,000 spent on a single wound.

Precision Medicine Market By Applications (Oncology, Cardiovascular Diseases, Central Nervous System, Infectious Diseases) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

$ 4325

This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2016, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.

Geriatric Care Services Market By Service Type (Skilled Nursing Care Facilities, Home Healthcare Services, Social Services, Continuing Care Retirement Communities, Assisted Living Facilities), By Service Provider (For-profit, Non-profit), By Payment Source (Public Expenditure, Private Expenditure, Out Of Pocket) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The global geriatric population is rising at an unprecedented rate. The pool of population aged 60 years is anticipated to double until 2050 and more than triple by 2100 (rising from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100). Aging of population has profound effects in terms of disease burden and social and healthcare systems.

Foot And Mouth Disease (FMD) Vaccines Market By Vaccine Type (Conventional Vaccines, Emergency Vaccines), By Animal Type (Cattle, Sheep & Goat, Swine, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global foot and mouth disease (FMD) vaccines market to reach US$ 2,935.1 Mn in 2026 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids.

Equine Healthcare Market By Product Type (Drug Type, Vaccine Type,Supplements and Additives), By Disease Type (West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus, Equine Influenza, Equine Herpes Virus)- Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

The global equine healthcare market held US$ 626.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2018 to 2026. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market.

Electronic Health Records (EHR) Market By Delivery (On-Premise Server Based, Cloud-Based, Web-Based), By Product (Inpatient HER, Ambulatory HER), By End-User (Hospitals, Clinics And Diagnostic Centers, Ambulatory Care Centers, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global electronic health records (EHR) market held US$ 24,222.5 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. EHRs are digital form of patient’s medical chart that deliver real-time patient records providing information instantly and securely to authorized user for medical decision making.

Dilated Cardiomyopathy Therapeutics Market By Treatment (Drug Class, Implantable Device) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The dilated cardiomyopathy therapeutics market is set to reach US$ xx Mn by 2026 from US$ xx Mn in 2017 featuring magnificent growth at a compounded annual growth rate (CAGR) of 4.7% during the forecast period from 2018 to 2026.

Diagnostic Testing For STD’s Market By Type (Syphilis Testing, Gonorrhea Testing, Chlamydia Testing, Herpes Simplex Virus Testing, Human Immunodeficiency Virus Testing, Human Papilloma Virus Testing, Others), By Location (Laboratory Testing, Point Of Care Testing) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The diagnostic testing for STD’s market is set to reach US$ 42,329.1 Mn by 2026 from US$ 19,716.9 Mn in 2017 performing steadily at a compounded annual growth rate (CAGR) of 8.9% during the forecast period from 2018 to 2026.

Cutaneous Mastocytosis Treatment Market By Drug Type (Antihistamines, Corticosteroids, Mast Cell Stabilizers, Sympathomimetic Agents, Photochemotherapy), By Pipeline Analysis (Phase III, Phase II) - Growth, Future Prospects and Competitive Analysis, 2018-2026

$ 4325

Cutaneous mastocytosis treatment market accounted for a market value of US$ 186.7 Mn in 2017 and projected to grow at a CAGR of 5.6% during the forecast period from 2018 to 2026. Cutaneous mastocytosis is a rare disease in which uncontrolled production of mast cells leads to skin complications such as lesions, blisters, and rashes with aggravated itching. The key causes of cutaneous mastocytosis are a mutation in KIT gene which leads to overproduction of mast cells and excess accumulation of mast cell in the skin leads to chronic as well as acute reactions.

Chemotherapy Induced Nausea And Vomiting Treatment Market By Drug Class (Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist, Dopamine Antagonist, Benzodiazepine, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The chemotherapy induced nausea and vomiting treatment market is set to reach US$ 3,626.1 Mn by 2026 from US$ 2,057.4 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2018 to 2026. As per the latest statistics provided by the National Cancer Institute in 2018 approximately 1,735,350 new cancer cases will be reported with an estimation of 609,640 people dying with cancer.

Cervical Cancer Treatment Market By Product (Chemotherapy, Targeted Therapy, Surgical Procedure, Radiation Therapy and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The cervical cancer treatment market will be highlighting excellent growth at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2018 to 2026. Cervical cancer occurs in women in age group ranging from 14 to 49 years. The human papillomavirus (HPV) is the main causative agent for the occurrence of cervical cancer which is sexually transmitted. Cervical cancer can be prevented by performing early screening test and vaccination using Gardasil against HPV infection.

Cervical Cancer Diagnostic Test Market By Diagnostic Test Type (PAP Tests, HPV Tests, Biopsy, Colposcopy, Cystoscopy) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global cervical cancer diagnostic test market is growing significantly, was valued at US$ 8,779.2 Mn in 2017 and expected to attain US$ XX Mn by 2026. Worldwide growing prevalence of cervical cancer along with growing female population aged between 25 to 60 years are the major factors driving the overall growth of the global cervical cancer diagnostic test market.

Cardiovascular Information Systems Market By Systems Type (CVIS, C-PACS), By Component (Software, Services, Hardware), By Delivery Mode (Web-Based CVIS, Onsite CVIS, Cloud-Based CVIS), By Application (Cardiac And Peripheral Catheterization, Hemodynamics Monitoring, Electrophysiology, Echocardiography, Cardiac CT, Cardiac MRA, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The cardiovascular information systems market stood at US$ 696.7 Mn in 2017 and projected to exhibit a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Cardiovascular information system (CVIS) is a kind of electronic health record specifically designed for cardiovascular solutions.

Cancer Diagnostics Market By Test Type (Digital Pathology, Genomic Testing, Cancer Biomarker Tests, Imaging, Endoscopy, Biopsy, Others), By Disease Condition (Breast Cancer, Lung Cancer, Prostate Cancer, Blood Cancer, Colorectal Cancer, Ovarian Cancer, Liver Cancer, Other Cancers) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global cancer diagnostics market to reach US$ 115.3 Bn in 2026 growing at compound annual growth rate (CAGR) of 6.1% during the forecast period from 2018 to 2026. The prime factors driving the global cancer diagnostics market is the rising prevalence of cancer worldwide.

Bronchitis Treatment Market By Type Of Drug Class (Antitussives/ Expectorants, Bronchodilators, Beta-Adrenergic Agonist, Systemic Corticosteroids, Inhaled Corticosteroids, Phosphodiesterase-4 Inhibitors, Analgesics, Antibiotics) - Growth, Future Prospects, Competitive Analysis, 2018 - 2026

$ 4325

Bronchitis treatment market accounted for a market value of US$ 3,345.8 Mn in 2017 and projected to grow at a CAGR of 4.9% during the forecast period from 2018 to 2026. Bronchitis treatment market is growing gradually throughout the forecast period due to strong product pipeline equipped with target-specific drugs, and rising prevalence & awareness related to the treatment & diagnosis of bronchitis.